Cover Image
市場調查報告書

原位雜合反應 (ISH) 的全球市場分析、預測 2019年:DNA、RNA、癌症診斷、細胞學、免疫學

In situ Hybridization Market by Type (DNA, RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019

出版商 MarketsandMarkets 商品編碼 338073
出版日期 內容資訊 英文 182 Pages
訂單完成後即時交付
價格
Back to Top
原位雜合反應 (ISH) 的全球市場分析、預測 2019年:DNA、RNA、癌症診斷、細胞學、免疫學 In situ Hybridization Market by Type (DNA, RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019
出版日期: 2015年08月13日 內容資訊: 英文 182 Pages
簡介

全球原位雜合反應 (ISH) 市場規模一般預期從2014年的5億5,440萬美金,2014年到2019年以4.2%的年複合成長率推移,估計到2019年達到6億8,100萬美元。

本報告提供全球原位雜合反應 (ISH) 市場相關調查、市場概要、市場的各種影響因素及市場機會分析、市場整體及各類型、應用、終端用戶、地區的市場趨勢與市場成長預測、競爭環境,及主要企業的簡介等彙整。

第1章 簡介

第2章 摘要整理

第3章 市場概要

第4章 市場動態

第5章 原位雜合反應 (ISH) 市場:各類型

第6章 原位雜合反應 (ISH) 市場:各應用領域

第7章 原位雜合反應 (ISH) 市場:各終端用戶

第8章 原位雜合反應 (ISH) 市場:各地區

第9章 競爭情形

第10章 企業簡介

  • ABBOTT
  • BIOGENEX
  • BIOSB
  • F. HOFFMANN-LA ROCHE LTD
  • SIGMA-ALDRICH CO. LLC.
  • ADVANCED CELL DIAGNOSTICS
  • AFFYMETRIX, INC.
  • EXIQON A/S
  • AGILENT TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC, INC.

第11章 附錄

圖表

目錄
Product Code: BT 3649

In-situ hybridization (ISH) is a powerful technique used for focusing on specific nucleic acid targets within fixed tissues and cells, to obtain temporal and spatial information about gene expression. The in-situ hybridization technique is divided into two types, namely DNA and RNA. This is because, normally ISH requires isolation of DNA or RNA which is done by separating it on a gel, blotting it onto nitrocellulose, and probing it with a complementary sequence.

The global in-situ hybridization market was valued at $554.4 million 2014, and is estimated to reach $681.0 million by 2019, at a CAGR of 4.2% from 2014 to 2019.

The global in-situ hybridization market is primarily driven by the increasing prevalence of cancer disease, growing usage of personalized medicines for its treatment, and rising number of initiatives undertaken by the government, such as create awareness about cancer and providing funding to support related researches.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis.

Some of the companies profiled in this report are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Agilent Technologies, Inc. (U.S.).

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the global in-situ hybridization market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to analyze the market, which in turn will help the firms in achieving greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global in-situ hybridization market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of product approvals, pipeline products, and product recalls.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for in-situ hybridization across geographies, exploit new distribution channels, new clientele base, and different pricing policies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global in-situ hybridization market. Detailed description regarding the related and unrelated diversification pertaining to this market.
  • Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies operational in the global in-situ hybridization market.

TABLE OF CONTENTS

1. INTRODUCTION

2. EXECUTIVE SUMMARY

3. MARKET OVERVIEW

4. MARKET DYNAMICS

5. IN-SITU HYBRIDIZATION MARKET, BY TYPE

6. IN-SITU HYBRIDIZATION MARKET, BY APPLICATION

7. IN-SITU HYBRIDIZATION MARKET, BY END USER

8. IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY

9. COMPETITIVE LANDSCAPE

10. COMPANY PROFILES

  • 10.1. ABBOTT
  • 10.2. BIOGENEX
  • 10.3. BIOSB
  • 10.4. F. HOFFMANN-LA ROCHE LTD
  • 10.5. SIGMA-ALDRICH CO. LLC.
  • 10.6. ADVANCED CELL DIAGNOSTICS
  • 10.7. AFFYMETRIX, INC.
  • 10.8. EXIQON A/S
  • 10.9. AGILENT TECHNOLOGIES
  • 10.10. THERMO FISHER SCIENTIFIC, INC.

11. APPENDIX

LIST OF TABLES

  • TABLE 1: In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
  • TABLE 2: DNA In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 3: DNA Fluorescent In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 4: DNA Chromogenic In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 5: RNA In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 6: RNA Fluorescent In-Situ Hybridization (FISH) Market, By Geography, 2012-2019 (USD MN)
  • TABLE 7: RNA Chromogenic In-Situ Hybridization (CISH) Market, By Geography, 2012-2019 (USD MN)
  • TABLE 8: In-Situ Hybridization Market, By Application, 2012-2019 (USD MN)
  • TABLE 9: Cancer Diagnostics Market, By Geography, 2012-2019 (USD MN)
  • TABLE 10: Cytology Market, By Geography, 2012-2019 (USD MN)
  • TABLE 11: Neuroscience Market, By Geography, 2012-2019 (USD MN)
  • TABLE 12: Immunology Market, By Geography, 2012-2019 (USD MN)
  • TABLE 13: Other Applications Market, By Geography, 2012-2019 (USD MN)
  • TABLE 14: Market, By End User, 2012 - 2019 (USD MN)
  • TABLE 15: Hospital Market, By Geography, 2012-2019 (USD MN)
  • TABLE 16: Pharma & Biotech Companies Market, By Geography, 2012-2019 (USD MN)
  • TABLE 17: Research Labs Market, By Geography, 2012-2019 (USD MN)
  • TABLE 18: Cros Market, By Geography, 2012-2019 (USD MN)
  • TABLE 19: Other End User Market, By Geography, 2012-2019 (USD MN)
  • TABLE 20: In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 21: North America In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
  • TABLE 22: North America DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 23: North America RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 24: North America In-Situ Hybridization Market, By Application, 2012-2019 (USD MN)
  • TABLE 25: North America In-Situ Hybridization Market, By End User, 2012-2019 (USD MN)
  • TABLE 26: Europe In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
  • TABLE 27: Europe DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 28: Europe RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 29: Europe: Market, By Application, 2012-2019 (USD MN)
  • TABLE 30: Europe: Market, By End User, 2012- 2019 (USD MN)
  • TABLE 31: APAC: Market, By Type, 2012- 2019 (USD MN)
  • TABLE 32: APAC DNA In-Situ Hybridization Market, By Technique, 2012- 2019 (USD MN)
  • TABLE 33: APAC RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 34: APAC: Market, By Application, 2012-2019 (USD MN)
  • TABLE 35: APAC: Market, By End User, 2012-2019 (USD MN)
  • TABLE 36: RoW: Market, By Type, 2012- 2019 (USD MN)
  • TABLE 37: RoW DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 38: RoW RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 39: RoW: Market, By Application, 2012-2019 (USD MN)
  • TABLE 40: RoW: Market, By End User, 2012- 2019 (USD MN)

LIST OF FIGURES

  • FIGURE 1: Market Size, 2014 & 2019
  • FIGURE 2: Market Size, 2014 & 2019
  • FIGURE 3: Market Size, 2014 & 2019
  • FIGURE 4: Market Size, 2014 & 2019 (USD MN)
  • FIGURE 5: Market, By Type, 2014 & 2019 (USD MN)
  • FIGURE 6: DNA In-Situ Hybridization Market, By Technique, 2014 & 2019 (USD MN)
  • FIGURE 7: RNA In-Situ Hybridization Market, By Technique, 2014 & 2019 (USD MN)
  • FIGURE 8: Market, By Application, 2014 & 2019 (USD MN)
  • FIGURE 9: Market, By End-User, 2014 & 2019 (USD MN)
  • FIGURE 10: In-Situ Hybridization Market, By Type, 2014 & 2019 (USD MN)
  • FIGURE 11: DNA In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 12: DNA Fluorescent In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 13: DNA Chromogenic In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 14: RNA In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 15: RNA Fluorescent In-Situ Hybridization (FISH) Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 16: RNA Chromogenic In-Situ Hybridization (CISH) Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 17: Market, By Application, 2014 & 2019 (USD MN)
  • FIGURE 18: Market, By Application, 2014 & 2019 (USD MN)
  • FIGURE 19: Cancer Diagnostics Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 20: Cytology Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 21: Neuroscience Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 22: Immunology Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 23: Other Application Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 24: Market, By End User, 2012 - 2019 (USD MN)
  • FIGURE 25: End-User Market, By Geography, 2014 & 2019 (USD MN)
  • FIGURE 26: Hospitals Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 27: Pharma & Biotech Companies Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 28: Research Labs Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 29: Cros Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 30: Others Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 31: In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 32: North America: Market, 2014 & 2019 (%)
  • FIGURE 33: Europe: Market, 2014 & 2019 (%)
  • FIGURE 34: APAC: Market, 2014 & 2019 (%)
  • FIGURE 35: RoW: Market, 2014 & 2019 (%)
Back to Top